“The Greatest Little Stock Nobody’s Ever Heard Of” (Marc Lichtenfeld)

Now this is a nice promise:

“If This Stock Doesn’t Double Between Now and June 25, I’ll Write You an Apology – Along With a Check for $1,250″
Of course, one assumes that this only applies to the folks who pony up that same $1,250 for a subscription to the Access Research Group newsletter (and, not inconsequentially, [...]

“#1 Pharmaceutical Trade for This Year” Stephen Leeb

It’s been a few weeks since we looked at a teaser from Dr. Stephen Leeb, and I sure do see his name out there a lot, so I thought this one might be interesting for a quick once-over.
And incidentally, yes, if you insist on using the Dr., I’ll try to remember to throw [...]

“Photon Beam Technology Kills Cancer in 16 Minutes”

This ad has been crashing in on Gumshoe beach in massive waves over the last week, so I thought it might be time to take a gander. It’s for the Xcelerated Profits report at Mt. Vernon Research — the last time I saw a similar ad it was from Karim Rahemtulla for this same [...]

More Biotech Riches …

I gave you a taste yesterday of the new stock teaser from Hot Stock Confidential.
Now, half of that taste was probably wrong, it turns out — read this comment for a better solution than Dendreon for the “active immunity” cancer fighter, (which, you’ll recall, was clearly a guess on my part). I stand by [...]

“Three Biotechs that Could Revolutionize Medicine (and make you RICH!)”

“Move over Geron, Genentech and Osiris… The next generation in revolutionary biotechs has arrived.
“(And they may be the only way to make money in this market!)
“Each one of these 3 breakout stocks could realistically bring you gains of 128%, 185%, or even 422% in the next 6 months!”
That heady promise introduces an ad from Hot [...]

“One Tiny Drug Developer Could Take Down Pfizer”

Taking down Pfizer — hasn’t that already been done? At least, if you think a drop of 60% or so in share price over five years for a “blue chip” company is a “takedown.”
But that’s the promise of a recent issue of the Penny Sleuth free email newsletter — and to find the details [...]

A Good Old Fashioned Newsletter Fight

I don’t see this very often, but it looks like there’s a little battle brewing between Ian Cooper and Rob Fannon … or probably more precisely, between Stansberry & Associates and Angel Publishing.
I don’t know if this has anything to do with it, but the two seem linked in several “sincerest form of [...]

“At $4, this is a dream stock at a bargain price …”

Tim Fields is telling us that the next big wave will be personalized medicine, and using genetic testing to customize treatments. We’ve heard that before from several newsletter editors, and it has been an investment theme for years. Will this little stock really revolutionize medicine and lead to untold riches for investors? First, I’ve got to figure out who it is for you.

“Hunt Down Cancer Cells and Zap them Dead” Access Group

Today’s teaser ad is from Marc Lichtenfeld and his Access Group — they specialize in part on medical and biotech stocks, and the first two ads we’ve looked at them are in that area. The first one was for the “$4 Cancer Detection Device that could go to $196,” which you might remember turned [...]

Access Group: “$4.75 Cancer Detection Device co. could got to $196″

This one comes in from what looks to be a new newsletter service called “The Access Group” that will run you $2,750 a year. Phew. This is a service that they claim will enable individual investors to get access to the kind of research hedge fund companies used to pay these analysts $30,000 [...]